Concepedia

Mitsutaka Nakamura

MN

Statistics

Publications

33

Citations

1.6K

H-Index

21

Active since

1976

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Sumitomo Chemical (Japan)

Takara (Japan)

Sumitomo Chemical (United States)

University of Oklahoma Health Sciences Center

Mitsutaka Nakamura is an author at Sumitomo Dainippon Pharma (Japan) specializing in neuropharmacology, medicine, and pharmacology.

Publications per year

1976–2012

33

Publications

33

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Tadashi Ishibashi, Tomoko Horisawa, Takeo Ishiyama et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 433 citations

, , +12

Lurasidone in the Treatment of Acute Schizophrenia

Mitsutaka Nakamura, Masaaki Ogasa, John Guarino et al. · The Journal of Clinical Psychiatry · 2009 · 192 citations

, , +17

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

Masaaki Ogasa, Tatsuya Kimura, Mitsutaka Nakamura et al. · Psychopharmacology · 2012 · 116 citations · Full text

, , +17

Pharmacological properties of SM-3997: A new anxioselective anxiolytic candidate.

Hiroshi Shimizu, Akira Hirose, Tohru Tatsuno et al. · The Japanese Journal of Pharmacology · 1987 · 86 citations · Full text

, , +15

Pharmacological Actions of SM-9018, a New Neuroleptic Drug with Both Potent 5-Hydroxytryptamine2 and Dopamine2 Antagonistic Actions

Akira Hirose, Terufumi Kato, Yukihiro Ohno et al. · The Japanese Journal of Pharmacology · 1990 · 60 citations · Full text

, , +14

1–5 of 33